Metasphere Labs Inc. (CSE:LABZ)
Canada · Delayed Price · Currency is CAD 0.2300
+0.0550 (31.43%)
At close: Feb 6, 2026
Metasphere Labs Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Operating Revenue | 0 | 0 | 2.2 | 0.65 | 7.01 | 0.52 |
Other Revenue | - | - | - | - | - | 0.01 |
| 0 | 0 | 2.2 | 0.65 | 7.01 | 0.53 | |
Revenue Growth (YoY) | -99.84% | -99.89% | 235.28% | -90.65% | 1211.16% | 2846.28% |
Cost of Revenue | 0 | 0 | 0.35 | 0.11 | 0.72 | 0.01 |
Gross Profit | 0 | 0 | 1.84 | 0.55 | 6.28 | 0.53 |
Selling, General & Admin | 0.43 | 0.63 | 1.04 | 2.81 | 6.19 | 0.22 |
Research & Development | 0.02 | 0.04 | 0.03 | 0.14 | 1.86 | 0.12 |
Amortization of Goodwill & Intangibles | - | - | 0.07 | 0.11 | 0.08 | - |
Other Operating Expenses | - | - | - | - | - | 0.01 |
Operating Expenses | 0.66 | 0.82 | 1.17 | 5.81 | 14.23 | 0.35 |
Operating Income | -0.65 | -0.82 | 0.67 | -5.27 | -7.95 | 0.17 |
Interest Expense | -0.02 | -0.02 | -0.05 | -0.14 | -0.03 | - |
Interest & Investment Income | - | 0 | - | 0.02 | - | - |
Currency Exchange Gain (Loss) | - | - | - | -0 | -0.02 | -0.03 |
Other Non Operating Income (Expenses) | 0.03 | 0.01 | -0.11 | -0.19 | -0.67 | - |
EBT Excluding Unusual Items | -0.64 | -0.83 | 0.51 | -5.58 | -8.68 | 0.14 |
Merger & Restructuring Charges | - | - | - | - | -0.38 | - |
Impairment of Goodwill | - | - | - | -3.32 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -0.43 | -0.33 | - |
Asset Writedown | - | - | -0.7 | -3.28 | -4.1 | - |
Other Unusual Items | -0.08 | -0.08 | 0.18 | 0.22 | 0.54 | - |
Pretax Income | -0.72 | -0.91 | -0.01 | -12.38 | -12.95 | 0.14 |
Income Tax Expense | - | - | - | - | -1.26 | 0.02 |
Earnings From Continuing Operations | -0.72 | -0.91 | -0.01 | -12.38 | -11.68 | 0.13 |
Earnings From Discontinued Operations | - | - | - | -0.16 | -0.38 | - |
Net Income | -0.72 | -0.91 | -0.01 | -12.55 | -12.06 | 0.13 |
Net Income to Common | -0.72 | -0.91 | -0.01 | -12.55 | -12.06 | 0.13 |
Net Income Growth | - | - | - | - | - | 981.12% |
Shares Outstanding (Basic) | 10 | 10 | 5 | 0 | 0 | - |
Shares Outstanding (Diluted) | 10 | 10 | 5 | 0 | 0 | - |
Shares Change (YoY) | 50.69% | 113.82% | 919.23% | 39.21% | - | - |
EPS (Basic) | -0.07 | -0.09 | -0.00 | -27.52 | -36.83 | - |
EPS (Diluted) | -0.07 | -0.09 | -0.00 | -27.52 | -36.83 | - |
Free Cash Flow | -0.73 | -1.21 | -1 | -2.03 | -1.15 | 0.27 |
Free Cash Flow Per Share | -0.07 | -0.12 | -0.21 | -4.46 | -3.52 | - |
Gross Margin | 8.00% | 8.00% | 83.97% | 83.22% | 89.68% | 98.32% |
Operating Margin | -26199.24% | -32918.56% | 30.73% | -804.59% | -113.52% | 32.09% |
Profit Margin | -28949.36% | -36386.08% | -0.65% | -1915.53% | -172.18% | 23.61% |
Free Cash Flow Margin | -29163.76% | -48465.36% | -45.39% | -310.18% | -16.45% | 49.80% |
EBITDA | - | -0.8 | 0.7 | -5.2 | -7.92 | - |
EBITDA Margin | - | - | 31.87% | - | -112.99% | - |
D&A For EBITDA | - | 0.03 | 0.03 | 0.07 | 0.04 | - |
EBIT | -0.65 | -0.82 | 0.67 | -5.27 | -7.95 | 0.17 |
EBIT Margin | - | - | 30.73% | - | -113.52% | 32.09% |
Effective Tax Rate | - | - | - | - | - | 12.08% |
Revenue as Reported | 0 | 0 | 2.2 | 0.65 | 7.01 | 0.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.